Ruxolitinib Tablets Receive FDA Approval for Hematologic Malignancies
The U.S. Food and Drug Administration (FDA) has approved Ruxolitinib tablets for the treatment of certain hematologic malignancies, mar...
Tovorafenib Approved in Europe for Children with BRAF-Altered Low-Grade Glioma
n Medical Review: This article was reviewed by Dr. Sophie Reynolds on May 14, 2026.nnThis marks an important milestone in the treatm...
FDA Fast-Tracks Plixorafenib for BRAF V600E–Mutated Brain Tumors
n Medical Review: This article was reviewed by Dr. Sophie Reynolds on April 14, 2026.nnBrain tumors, especially high-grade gliomas, ...
What are the 4 stages of lung cancer?
n Medical Review: This article was reviewed by Dr. Sophie Reynolds on April 7, 2026.nnLung cancer staging is a critical step in unde...
Sunvozertinib vs Chemo: A PFS Breakthrough in EGFR+ NSCLC
n Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 25, 2026.nnThe treatment landscape for EGFR-mutated non–...
Atirmociclib and Fulvestrant Together Delay Cancer Progression in HR+/HER2– Cases
Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 23, 2026.
Advancements in breast cancer treatment continue t...
ESGO 2026 Insights: The Future of Ovarian Cancer Care
n Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 14, 2026.nnThe 27th European Congress on Gynaecological ...
Trifluridine/Tipiracil-Associated Neutropenia in Metastatic Colorectal Cancer: What It Means for Treatment Outcomes
n Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 10, 2026.nnMetastatic colorectal cancer (mCRC) remains o...
New Hope for Advanced Prostate Cancer: Enzalutamide and Radium-223 Combination Shows Survival Benefit
n Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 5, 2026.nnAdvances in prostate cancer treatment continue...
Zongertinib Receives FDA Accelerated Approval for HER2+ NSCLC Treatment
n Medical Review: This article was reviewed by Dr. Sophie Reynolds on February 28, 2026.nnThe U.S. Food and Drug Administration has ...